Dutasteride

Description

Dutasteride is useful for treating benign prostatic hyperplasia (BPH); colloquially known as an “enlarged prostate”

Specification:

 

ITEMS SPECIFICATION
DESCRIPTION WHITE OR ALMOST WHITE CRYSTALLINE POWDER
IDENTIFICATION HPLC
LOSS ON DRYING Max.0.5%
MELTING POINT 246.0℃~252.0℃
RESIDUE ON IGNITION Max.0.1%
HEAVY METALS Max.20ppm
RELATED SUBSTANCES TOTAL Max.1.0%
SINGLE MAXIMUM IMPURITY 0.5%
ASSAY (BASED ON DRYING) 97.0% ~ 103.0%
RESIDUAL SOLVENTS(GC)

-ACETONE

-DICHLOROMETHANE

-ETHYL ACETATE

-METHANOL

-TOLUENE

 

N.m.t. 5000ppm

N.m.t. 600ppm

N.m.t. 5000ppm

N.m.t. 5000ppm

N.m.t. 890ppm

 

Packaging details:

 

Packaging details: 25kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum.
Storage: Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat
Shelf Life: 5 years if sealed and store away from direct sun light.

Additional Information

The most widely recognized markets for this item incorporate the accompanying nations. If you don’t mind ask with us if your nation or district isn’t recorded:

ASIA: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, and so forth.

AFRICA: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , and so forth.

NORTH & SOUTH AMERICA: USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, and so forth .

EUROPE: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, and so forth.

OCEANIA: Australia, New Zealand, Fiji, and so forth.

Category:

Description

  • Product Name : Dutasteride
  • Grade : IP / BP / USP
  • Therapeutic Category : Treat benign Prostatic Hyperplasia
  • CAS No : 164656-23-9
  • COA : Available
  • MSDS : Available